Arrowhead Pharmaceuticals, Inc. · NASDAQ:ARWR
The Vanguard Group reported a 11.24% stake in Arrowhead Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 11.24% stake in Arrowhead Pharmaceuticals, Inc., 15,525,072 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 11.24%
- Shares
- 15,525,072
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 11.24% | 15,525,072 |
Source
Related
- Arrowhead Pharmaceuticals, Inc.
- The Vanguard Group
- Arrowhead Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 26, 2026
- Form 4 · Olukotun Adeoye Y · Aug 20, 2026
- Form 4 · Perry Michael S · Aug 20, 2026
- Schedule 13G/A · Avoro Capital Advisors LLC · Aug 14, 2026
- Schedule 13G/A · Vanguard Portfolio Management LLC · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 27, 2026